Associate Professor Jay Lu

Prof Jay Lu attended his Medical Doctor (M.D.) from the Medical School of the State University of New York at Buffalo, USA, and his M.B.A. from both the University of California, Los Angeles and the National University of Singapore. He completed his residency training in radiation oncology at University of Miami Jackson Memorial Hospital. After his specialty training, Dr. Lu started his academic career at the Department of Radiation Oncology at the National University Cancer Institute of Singapore.

He also serves a number of international publishing and public corporations as advisor or independent board member of the board of directors. Dr. Lu is very productive in clinical practice, academic activity, as well as extra-curriculum activities. In addition to his busy clinical and research work in head and neck cancers and gastrointestinal cancers, he has edited 4 oncology texts or reference books, contributed to over 25 book chapters, and more than 50 original articles in international peer-reviewed journals.

Education

• M.D. (Medicine) from the State University of New York at Buffalo
• M.B.A. from UCLA and NUS
• B.S. (Biochemistry) from the State University of New York at Buffalo

Specialty Interests

• Nasopharyngeal cancer
• Pancreatic cancer

Professional Membership

• Member, American Society of Therapeutic Radiology and Oncology
• Committee Member, Chinese Society of Clinical Oncology
• Chairperson, Elekta Nasopharyngeal Cancer Research Consortium
• Fellow, FAMS

Selected Publications

1. Wong S, Back M, Lee KM, Tan PW, Baggarley S, Lu JJ*. Can Radiation Therapy Treatment Planning System accurately predict for Surface doses in Postmastectomy Radiation Therapy Patients? Medical Dosimetry Journal (Accepted) (Tier 3)
2. Wong S, Kaur A, Back M, Lee KM, Baggarley S, Lu JJ*. An ultrasonographic evaluation of skin thickness in breast cancer patients after postmastectomy radiation therapy. Radiat Oncol, 2011, 6:9 (Tier 3)
3. Qiu S, Lin S, Tham IWK, Pan J, Lu J, Lu JJ*. Intensity-modulated radiation therapy in the treatment of locally recurrent nasopharyngeal carcinoma: A retrospective study of 70 consecutive cases. Int J Radiat Oncol Biol Phys, 2011 (Under minor revision) (Tier 1)
4. Wang X, Xiong X, Lu JJ, Zhu G, He S, Hu C, Ying H. The in vivo study on radiobiologic effect of prolonged delivery time to tumor control in C57BL mice implanted with Lewis lung caner. Radiat Oncol, 2011, 6:4 (Tier 3)
5. Lin S, Tham IWK, Pan J, Han L, Lu JJ*. Radiation therapy to primary and metastatic foci in addition to systemic cytotoxic chemotherapy improves survival patients with low volume metastatic nasopharyngeal carcinoma. Am J Clin Oncol, 2011 (Accepted) (Tier 4)
6. Sun W, Leong CN, Zhang Z, Lu JJ. Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: A pooled analyses of clinical evidence. Radiat Oncol, 2010, 5:28 (Tier 3)
7. Lin S, Lu JJ*, Han L, Chen Q, Pan J. Combined chemoradiation therapy for definitive treatment of nasopharyngeal carcinoma: Experience of 370 consecutive cases. BMC Cancer, 2010, 10, 39. (Tier 3)
8. Peng J, Lu JJ, Xu Y, Guan Z, Wang M, Cai G, Cai S. A standardized pelvic drainage of anastomotic leaks following anterior resection without diversional stomas. Am J Surg, 2010, 199(6): 753-8 (Tier 2)
9. Tham IWK, Lin S, Pan J, Lu JJ*, Han L, Wee J. Treatment outcome after intensity-modulated radiation therapy for patients with stage IIB nasopharyngeal carcinoma. Am J Clin Oncol, 2010, Accepted. (Tier 4)
10. Kong L, Lu JJ*, Hu C, Guo X, Wu Y, Zhang Y. Radiation induced cranial nerve palsy: A prospective cross-sectional study of nasopharyngeal cancer patients 15 treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys, 2010 June 2. [Epub ahead of print]. (Tier 1)
11. Wang X, Lu JJ*, Xiong X, Zhu G, Ying H, He S, Hu W, Hu C. Anatomic and dosimetric changes during the treatment course of intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma? Med Dosim, 2010, 35(2): 151-7 (Tier 3)
12. Gao Y, Zhu G, Lu JJ, Ying H, Lin K, Wu Y, Hu C. Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys, 2010, 99(5): 1397-402 (Tier 1)
13. Zhang H, Dong B, Lu JJ, Yao X, Zhang S, Dai B, Shen Y, Zhu Y, Ye D, Huang Y. Efficacy of sorafenib on metastatic renal cell carcinoma in asian patients: Results from a multicenter study. BMC Cancer, 2009, 9: 249. (Tier 3)
14. Li Z, Yu Y, Lu JJ, Luo Q, Wu C, Liao M, Zheng Y, Ai X, Gu L, Lu S. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China. J Thorac Oncol, 2009, 4(6): 702-9 (Tiers N/A; Impact Factor=4.54)
15. Zhou J, Chen H, Lu JJ, Xiang J, Zhang Y, Hu H, Zhou X, Luo X, Yang F, Tam J. Application of a modified McKeown procedure (thoracoscopic esophageal mobilization three-incision esophagectomy) in esophageal cancer surgery: Initial experience with 30 cases. Dis Esophagus, 2009, 22(8): 687-93 (Tier 4)
16. Lin S, Pan J, Han L, Zhang X, Liao X, Lu JJ. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: Reports on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys, 2009, 75(4): 1071-8. (Tier 1)
17. Chen H, Lu JJ, Zhou J, Luo X, Liu Q, Tam J. Anterior versus posterior routes of reconstruction after esophagectomy: A comparative anatomic study. Annals of Thoracic Surgery, 2009, 87(2): 400-4 (Tier 3)
18. Li XY, Liu QF, Fang H, Qi SN, Wang H, Wang WH, Song YW, Lu JJ, Jin J, Wang SL, Liu YP, Lu N, Liu XF, Yu ZH. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma. Clin Cancer Res, 2009, 15(8): 2905-12 (Tier 1)
19. Pan J, Kong L, Lin S, Lin S, Chen G, Chen Q, Lu JJ. The Clinical significance of coexpression of cyclooxygenases-2 (COX-2), vascular endothelial growth factors (VEGF), and epidermal growth factor receptor (EGFR) in nasopharyngeal carcinoma. Laryngoscope, 2008, 118(11): 1970-5 (Tier 1)
20. Li YX, Fang H, Liu QF, Lu J, Qi SN, Wang H, Jin J, Wang WH, Liu YP, Song YW, Wang SL, Liu XF, Feng XL, Yu ZH. Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring. Blood, 2008,Oct 15;112(8): 3057-64. (Tier 1)
21. Fu S, Lu JJ*, Zhang Q, Yang Z, Peng L, Xiong F. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma. Int J Radiat Oncol Biol Phys, 2008, 72(5): 1488-94. (Tier 1)
22. Shen C, Lu JJ*, Gu Y, Zhu G, Hu C, He S. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy. Laryngoscope, 2008, 118(7): 1206-10 (Tier 1)
23. Zhang Q, Shen F, Liu T, Peng L, Huang G, Lu JJ. Adjuvant intraoperative electron radiotherapy and external beam radiotherapy for locally advanced transitional cell carcinoma of the ureter. Urol Oncol, 2009, 27(1): 14-20 (Tier 3)
24. Peng J, Lu JJ*, Zhu J, Xu Y, Lu H, Lian P, Cai G, Cai S. Prediction of locoregional recurrence by CD44v6 after total mesorectal resection for locally advanced rectal cancer. Cancer J, 2008, 14(1): 54-61. (Tier 3)
25. Lu JJ, Kong L, Shakespeare TP, Loh KST, Zhang Q, Lee KM, Tan TKL. Prospective Phase II Trial of Concomitant Boost Radiotherapy for Stage II Nasopharyngeal Carcinoma. Oral Oncol, 2007, 44(7): 703-9 (Tier 1)